| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e523971ebd759b3c9f67fc3e524df29d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 |
| filingDate |
2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb8611f6e9ef898c740749c51f24432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a07be4f76bb71a189b319d2f93fde72 |
| publicationDate |
2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017163190-A1 |
| titleOfInvention |
Amorphous ixazomib citrate and solid dispersion thereof |
| abstract |
The present invention relates to an amorphous Ixazomib citrate and its process for the preparation. Further, the present invention relates to solid dispersion of amorphous Ixazomib citrate and its process for the preparation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018158697-A1 |
| priorityDate |
2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |